TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer.

Kimberly L Blackwell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.